Sky Investment Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,081
Closed -$314K 101
2018
Q2
$314K Sell
1,081
-110
-9% -$30.9K 0.13% 82
2018
Q1
$326K Buy
1,191
+50
+4% +$15.5K 0.13% 83
2017
Q4
$363K Sell
1,141
-10
-0.9% -$3.21K 0.14% 80
2017
Q3
$360K Hold
1,151
0.15% 80
2017
Q2
$312K Hold
1,151
0.13% 80
2017
Q1
$315K Sell
1,151
-30
-3% -$8.48K 0.14% 79
2016
Q4
$335K Sell
1,181
-90
-7% -$26.7K 0.16% 76
2016
Q3
$398K Sell
1,271
-50
-4% -$14.8K 0.19% 75
2016
Q2
$319K Hold
1,321
0.15% 74
2016
Q1
$344K Buy
1,321
+20
+2% +$5.28K 0.17% 70
2015
Q4
$399K Sell
1,301
-250
-16% -$71.8K 0.2% 69
2015
Q3
$453K Buy
+1,551
New +$512K 0.25% 64

Other funds holding BIIB

Sky Investment Group's BIIB Position: Q3 2018 in Review

Sky Investment Group sold out of Biogen (BIIB) in Q3 2018, closing a stake of 1,081 shares — an estimated $314K sold.

Sky Investment Group first reported a position in BIIB in Q3 2015 and held it in 12 quarters. The position peaked at $453K in Q3 2015. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Sky Investment Group reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Sky Investment Group sold 1,081 Biogen shares in Q3 2018, an estimated $314K.
  • Sky Investment Group first reported a position in Biogen in Q3 2015 and held it in 12 quarters.
  • Sky Investment Group's Biogen position peaked at $453K in Q3 2015.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Sky Investment Group's 13F filing for Q3 2018, filed 11 Oct 2018.